A few weeks into my Doctor of Professional Practice (DPP) journey in Regulatory Science and Clinical Research Management, one theme continues to resonate: the strength of the evidence we generate depends on the quality, accuracy, and relevance of the data behind it.

This is not a new concept for me, but my doctoral studies are reinforcing its importance from a broader regulatory and clinical research perspective. Throughout my career in clinical research, clinical data, and real-world data and evidence (RWD/RWE), I’ve seen firsthand that generating meaningful evidence requires more than access to data. It requires fit-for-purpose data, clearly defined standards, appropriate governance and quality controls, and disciplined best practices throughout the data lifecycle.

What I’m especially appreciating about this doctoral journey is how it brings together disciplines that have shaped my professional development. My clinical research training has reinforced the importance of scientific rigor, research quality, and protecting the integrity of the evidence-generation process.

My project and program management background has reinforced something equally important: strong outcomes depend on how well we plan, govern, execute, manage risk, and continuously improve—and how effectively we communicate those plans in a business setting to create alignment, support informed decision-making, and drive successful execution.

My work in data and RWD/RWE has continually connected the two—translating research and business questions into data requirements and building the operational, governance, and quality practices needed to generate fit-for-purpose evidence.

This semester, I intentionally chose Medical Diagnostic Regulation as an elective to broaden my regulatory knowledge beyond drug and investigational-product regulation. It has been an opportunity to examine these principles through a different regulatory lens and reinforce how interconnected regulatory science, clinical research, data quality, and operational excellence are.

As technology, AI, and new sources of real-world data expand what is possible, I believe these foundations become even more important. Innovation can change how we generate and use data, but it does not diminish the need for reliable, relevant, traceable data—or disciplined processes for generating it.

It is still early in my doctoral journey, and I’m looking forward to connecting new regulatory perspectives with the clinical research, data, and program leadership principles that have shaped my career.

High-quality evidence begins with high-quality data—and generating both requires scientific rigor and veracity, disciplined execution, effective communication, and intentional quality by design.